BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Endothelial cell
,
Autoimmunity
,
Vitamin E
,
rs6983267
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ruxolitinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
XIST
BCL3
CHAC1
ERAP2
KRTAP4-3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cell periphery
CHEN_METABOLIC_SYNDROM_NETWORK
NUYTTEN_EZH2_TARGETS_UP
response to organic substance
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Skin post-5/6wk or 12wk of treatment with IL-15 pathway inhibitors or PBS following alopecia graft
Skin from alopecia areata allografts treated with ruxolitinib or tofacitinib
Acute erythroleukemia HEL cells treated with ruxolitinib, pevonedistat, or both
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Renal proximal tubule epithelial cells treated with IFNA1, IFNB1, IFNG, IL1B and ruxolitinib
Explore Curated Studies Results
Literature
Most Relevant Literature
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis.
Bilateral, sequential orbital inflammatory syndrome associated with ruxolitinib.
Utilization of Topical Ruxolitinib in Dermatology: A Review.
Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo.
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ruxolitinib in Combination With Autotransplant
Ruxolitinib In GvHD
Ruxolitinib in the Treatment of Covid-19
Ruxolitinib for Cancer Cachexia
Ruxolitinib in Seborrheic Dermatitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ